Block Listing - Six Monthly Review

+-------------------------------------------------------------------+
| Name of Company:                        | Hikma Pharmaceuticals   |
|                                         | PLC                     |
|-----------------------------------------+-------------------------|
| Name of scheme:                         | Hikma Pharmaceuticals   |
|                                         | PLC 2004 Stock Option   |
|                                         | Plan                    |
|-----------------------------------------+-------------------------|
| Period of return:                       | 6 October 2007          |
| From:                                   |  To: 11 April 2008      |
|-----------------------------------------+-------------------------|
| Balance under block scheme:             | 1,405,400 ordinary      |
|                                         | shares of 10 pence each |
|-----------------------------------------+-------------------------|
| The amount by which the block scheme    | 2,432,400 ordinary      |
| has  been increased, if the scheme has  | shares of 10 pence      |
| been increased since the date of the    |                         |
| last return:                            |                         |
|-----------------------------------------+-------------------------|
| Number of securities issued/allotted    | 1,856,200 ordinary      |
| under scheme during period:             | shares of 10 pence each |
|-----------------------------------------+-------------------------|
| Balance under scheme not yet issued/    | 1,981,600 ordinary      |
| allotted at end of period               | shares of 10 pence each |
|-----------------------------------------+-------------------------|
| Number and class of securities          | 166,537,951 ordinary    |
| originally listed and the date of       | shares of 10 pence each |
| admission                               | originally listed on 1  |
|                                         | November 2005           |
|-----------------------------------------+-------------------------|
| Total number of securities in issue at  | 188,307,607 ordinary    |
| the end of the period                   | shares of 10 pence each |
+-------------------------------------------------------------------+



                                    - ENDS -

Enquiries:

Hikma Pharmaceuticals PLC               [phone]
Henry Knowles, Company Secretary
Susan Ringdal, Investor Relations Director

Notes to Editors

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics". Hikma's operations are based
principally in the Middle East and North Africa ("MENA") region,
where it is a market leader and sells across 17 countries, the United
States and Europe. In 2007, the Group achieved revenues of $449
million (2006 $317 million) and profit attributable to shareholders
of $63 million (2006 $55 million). For news and other information,
please visit www.hikma.com .

---END OF MESSAGE---